Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Gri Bio Inc (GRI)

Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,226
  • Shares Outstanding, K 2,515
  • Annual Sales, $ 0 K
  • Annual Income, $ -8,210 K
  • EBIT $ -10 M
  • EBITDA $ -8 M
  • 60-Month Beta -1.45
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.32

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/25
See More
  • Average Estimate -1.11
  • Number of Estimates 1
  • High Estimate -1.11
  • Low Estimate -1.11
  • Prior Year -11.39
  • Growth Rate Est. (year over year) +90.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5800 +6.33%
on 11/03/25
2.2758 -26.18%
on 10/21/25
-0.2900 (-14.72%)
since 10/07/25
3-Month
1.1500 +46.09%
on 08/11/25
2.8700 -41.46%
on 09/11/25
+0.4300 (+34.40%)
since 08/07/25
52-Week
1.1000 +52.73%
on 04/09/25
16.9490 -90.09%
on 11/14/24
-13.2052 (-88.71%)
since 11/07/24

Most Recent Stories

More News
GRI Bio Reports 6-Week Interim Lung Function Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)

No decline in lung function observed at 6-week interim analysis  builds upon positive safety and biomarker data Phase 2a study fully enrolled; Topline data on track for Q3 2025 Currently available...

GRI : 1.6800 (-4.55%)
GRI Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Live webcast presentation with CEO, Dr. Marc Hertz, on September 9 th at 3:00 PM ET LA JOLLA, CA, Sept. 03, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”),...

GRI : 1.6800 (-4.55%)
JTC Team Companies to Present in Webull Corporate Connect Webinar Series: Biotech/MedTech on August 19-21, 2025

Register for the three-day event here

AKTX : 0.6385 (+3.72%)
NUWE : 2.87 (+3.24%)
AIM : 1.6800 (+0.60%)
AMIX : 0.7952 (-7.58%)
SNTI : 1.9500 (+7.73%)
CNSP : 6.57 (-4.92%)
NVNO : 0.6483 (-1.22%)
MBRX : 0.4890 (+7.12%)
GRI : 1.6800 (-4.55%)
GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Live video webcast on Wednesday, August 20 th at 2:20 PM ET LA JOLLA, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology...

GRI : 1.6800 (-4.55%)
GRI Bio CEO, Marc Hertz, Participates in Virtual Investor “What This Means” Segment

Access the “What This Means” segment here LA JOLLA, CA, July 31, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing...

GRI : 1.6800 (-4.55%)
GRI Bio Reports 6-Week Interim Biomarker Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”) 

Biomarkers at 6-week interim analysis show a positive impact on fibrogenesis, fibrolysis and potentially the initiation of a repair response The Independent Data Monitoring Committee (IDMC) has recommended...

GRI : 1.6800 (-4.55%)
GRI Bio Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

– Video webcast now available on-demand LA JOLLA, CA, July 22, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an...

GRI : 1.6800 (-4.55%)
JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live

- Video webcasts from participating companies now available here

AKTX : 0.6385 (+3.72%)
NUWE : 2.87 (+3.24%)
OTLK : 1.1900 (+0.85%)
AMIX : 0.7952 (-7.58%)
SNTI : 1.9500 (+7.73%)
CNSP : 6.57 (-4.92%)
PALI : 1.6800 (+1.20%)
NVNO : 0.6483 (-1.22%)
GRI : 1.6800 (-4.55%)
MBRX : 0.4890 (+7.12%)
JTC Team Announces Participating Line Up for the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference

- Video webcasts to be available on-demand Tuesday, July 22nd

AKTX : 0.6385 (+3.72%)
NUWE : 2.87 (+3.24%)
OTLK : 1.1900 (+0.85%)
AMIX : 0.7952 (-7.58%)
AIM : 1.6800 (+0.60%)
SNTI : 1.9500 (+7.73%)
CNSP : 6.57 (-4.92%)
PALI : 1.6800 (+1.20%)
NVNO : 0.6483 (-1.22%)
GRI : 1.6800 (-4.55%)
MBRX : 0.4890 (+7.12%)
GRI Bio Completes Enrollment in Phase 2a Study of GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”)

GRI : 1.6800 (-4.55%)

Business Summary

GRI Bio Inc. is a clinical stage biopharmaceutical company which focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated. GRI Bio Inc., formerly known as Vallon Pharmaceuticals Inc., is based in PHILADELPHIA, PA.

See More

Key Turning Points

3rd Resistance Point 1.9200
2nd Resistance Point 1.8400
1st Resistance Point 1.7600
Last Price 1.6800
1st Support Level 1.6000
2nd Support Level 1.5200
3rd Support Level 1.4400

See More

52-Week High 16.9490
Fibonacci 61.8% 10.8947
Fibonacci 50% 9.0245
Fibonacci 38.2% 7.1543
Last Price 1.6800
52-Week Low 1.1000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar